Clin Exp Metastasis 2005, 22: 503–511.CrossRefPubMed 20. Hata K, Dhar DK, Watanabe selleck Y, Nakai H, Hoshiai H: Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 2007, 43: 1452–1459.CrossRefPubMed 21. Schmid K, Wang X, Haitel A, Sieghart W, Peck-Radosavljevic M, Bodingbauer M, Rasoul-Rockenschaub S, Wrba F: KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 2007, 450: 143–149.CrossRefPubMed 22. Dhillo WS, Murphy KG, Bloom SR: The neuroendocrine physiology of kisspeptin in the human. Rev Endocr Metab Disord
2007, 8: 41–46.CrossRefPubMed 23. Mead EJ, Maguire JJ, Kuc RE, Davenport AP: Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 2007, 151: 1143–1153.CrossRefPubMed 24. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, Kami K, Ito D, Peiper SC, Broach JR, Oishi S, Niida A, Fujii N, Imamura M: Metastin and its variant forms suppress migration mTOR inhibitor of pancreatic cancer cells. Biochem Biophys Res Commun 2004, 315: 85–92.CrossRefPubMed 25. Katagiri F, Tomita K, Oishi S, Takeyama M, Fujii N: Establishment and clinical application of enzyme immunoassays for determination of luteinizing hormone releasing hormone and metastin.
J Pept Sci 2007, 13: 422–429.CrossRefPubMed 26. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 6th edition. New York: Wiley-Liss; 2002. 27. Kitagawa T, Shimozono T, Aikawa T, Yoshida T, Nishimura H: Preparation and characterization of hetero-bifunctional cross-linking reagents for protein modifications. Chem Pharm
Bull 1981, 29: 1130–1135. 28. Harms JF, Welch DR, Miele ME: KISS1 metastasis suppression and emergent pathways. Clin Exp Metastasis 2003, 20: 11–18.CrossRefPubMed 29. Stafford LJ, Xia C, Ma W, Cai Y, Liu M: Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res 2002, 62: 5399–5404.PubMed 30. Yan C, Wang H, Boyd DD: KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. J Biol SPTLC1 Chem 2001, 276: 1164–1172.CrossRefPubMed 31. Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C, Malli R, Sharabi A, Hiden U, Graier W, Knofler M, Andreae F, Wagner O, Quaranta V, Desoye G: Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004, 117: 1319–1328.CrossRefPubMed 32. Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee JU, Doi R, Arii S, Imamura M: Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 1998, 82: 642–650.CrossRefPubMed 33.